P/B
1,9
Utah Medical Products
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
$235.5M
Market Cap • 9/18/2026
1978
(48 years)
Founded
1982
(44 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
6,5
P/EBITDA
18,5
P/OCF
19,9
P/FCF
20,6
P/E
22,5
BVPS
38,2
EPS
3,3
Market Cap
Market Cap
235,5M
EV
148,1M
EV/Revenue
4,1
EV/EBITDA
11,6
EV/EBIT
14,4
Payout
Dividend Per Share
1,2
Dividend Yield
1,7%
Buyback Yield
0,8%
Total Yield
2,5%
Dividend Yield 5Y
1,9%
Payout
37,6%
Retained Earnings
132M
Profitability
Gross Margin
57,9%
EBITDA Margin
35,2%
EBIT Margin
28,4%
Net Margin
29%
D&A/EBITDA
0%
R&D/Revenue
1,9%
Capex/Revenue
1,1%
Capex/D&A
16,3%
Capex/OCF
3,4%
SBC/OCF
3,4%
% PPE
7,7%
% Goodwill
11,2%
ROE
8,8%
ROIC
23,4%
Growth
CAGR Revenue 5Y
-4,8%
CAGR Op. Income 5Y
-9,1%
CAGR Net Income 5Y
-3,9%
CAGR EPS 5Y
-1,3%
CAGR OCF 5Y
-10,8%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
48,6
Quick Ratio
44
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!